| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Early Stage, Seed |
| Investment Range | €250,000 - €750,000 |
RH Capital is an impact-first venture capital fund that operates under Rhia Ventures with a focus on stimulating innovation and equity in women's health. They are dedicated to early and growth-stage investment in women's health companies. RH Capital endeavors to advance reproductive and maternal health equity by leveraging the tools of capitalism to bring the needs and perspectives of underrepresented people to the forefront.
With a minimum investment of $250,000 and a maximum of $750,000, they support early-stage startups and seed ventures that promise to revolutionize women's health and improve health equity in the United States.
Their vision is to create a world where every woman and birthing person can thrive with full autonomy over their reproductive and maternal health.
RH Capital’s activities extend beyond investment to include ecosystem building, narrative change, and corporate advocacy designed to promote corporate responsibility and improve public policy regarding reproductive and maternal health.
They work with investors, activists, innovators, and entrepreneurs to construct a vibrant, equitable reproductive and maternal health market in the U.S and tackle challenges such as the high maternal mortality rates, gaps in contraceptive use, and minimal innovation in contraceptives since the 60s.
Rhia Ventures views this multifaceted approach as crucial to shifting harmful social norms that influence the market and ensuring a future where reproductive rights and health are prioritized and accessible.
We invest in early and growth-stage women's health companies.

